DANAMI-3 PRIMULTI

Complete Revascularization Versus Treatment of the Culprit Lesion Only in Patients with ST-segment Elevation Myocardial Infarction and Multivessel Disease - The Lancet - 2015

Brief Summary:

In patients undergoing PCI for STEMI found to have multivessel CAD, FFR-guided complete revascularization is associated with a 9% absolute reduction in major cardiovascular adverse events (death, MI, revascularization) at 27 months. This was driven primarily by an 12% absolute reduction in ischemia-driven revascularization.

Reference: http://www.ncbi.nlm.nih.gov/pubmed/26347918

Comments